Nanomechanics and sodium permeability of endothelial surface layer modulated by hawthorn extract WS 1442

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Peters, Wladimir ^a   Drueppel, Verena ^a   Kusche Vihrog, Kristina ^a   Schubert, Carola ^b   Oberleithner, Hans ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CRATAEGUS EXTRACT; SODIUM; FLAVONOID; HEPARIN LYASE; NANOPARTICLE; PLANT EXTRACT;

ANIMAL TISSUE; AORTA; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL MEMBRANE PERMEABILITY; CELL SURFACE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; EPIFLUORESCENCE MICROSCOPY; EX VIVO STUDY; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; ANIMAL; BIOLOGICAL MODEL; CATTLE; CELL LINE; CHEMISTRY; CRATAEGUS; CYTOLOGY; DRUG EFFECT; FLUORESCENCE MICROSCOPY; IN VITRO STUDY; METABOLISM; SURFACE PROPERTY;

CRATAEGUS; MURINAE;

ANIMALS; CATTLE; CELL LINE; CELL MEMBRANE PERMEABILITY; CRATAEGUS; ENDOTHELIAL CELLS; FLAVONOIDS; HEPARIN LYASE; HUMANS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NANOPARTICLES; PLANT EXTRACTS; SODIUM; SURFACE PROPERTIES;

EID: 84855612545     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029972     Document Type: Article

References (46)

1. Oberleithner H, de Wardener HE, (2011) Sodium: a wolf in sheep's clothing. Blood Purif 31: 82-85.
2. Siegel G, Walter A, Kauschmann A, Malmsten M, Buddecke E, (1996) Anionic biopolymers as blood flow sensors. Biosens Bioelectron 11: 281-294.
3. Oberleithner H, Riethmuller C, Schillers H, MacGregor GA, de Wardener HE, et al. (2007) Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A 104: 16281-16286.
4. Florian JA, Kosky JR, Ainslie K, Pang Z, Dull RO, et al. (2003) Heparan sulfate proteoglycan is a mechanosensor on endothelial cells. Circ Res 93: e136-e142.
5. Thi MM, Tarbell JM, Weinbaum S, Spray DC, (2004) The role of the glycocalyx in reorganization of the actin cytoskeleton under fluid shear stress: a "bumper-car" model. Proc Natl Acad Sci U S A 101: 16483-16488.
6. Weinbaum S, Zhang X, Han Y, Vink H, Cowin SC, (2003) Mechanotransduction and flow across the endothelial glycocalyx. Proc Natl Acad Sci U S A 100: 7988-7995.
7. Becker BF, Chappell D, Jacob M, (2010) Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol 105: 687-701.
8. Vink H, Duling BR, (2000) Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am J Physiol Heart Circ Physiol 278: H285-H289.
9. Jacob M, Bruegger D, Rehm M, Welsch U, Conzen P, et al. (2006) Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 104: 1223-1231.
10. Rehm M, Zahler S, Lotsch M, Welsch U, Conzen P, et al. (2004) Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 100: 1211-1223.
11. Wilsie LC, Orlando RA, (2003) The low density lipoprotein receptor-related protein complexes with cell surface heparan sulfate proteoglycans to regulate proteoglycan-mediated lipoprotein catabolism. J Biol Chem 278: 15758-15764.
12. Tovar AM, de Mattos DA, Stelling MP, Sarcinelli-Luz BS, Nazareth RA, et al. (2005) Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II. Biochim Biophys Acta 1740: 45-53.
13. Hoogewerf AJ, Kuschert GS, Proudfoot AE, Borlat F, Clark-Lewis I, et al. (1997) Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36: 13570-13578.
14. Yamashita K, Fukushima K, (2004) The carbohydrate recognition by cytokines modulates their physiological activities. Glycoconj J 21: 31-34.
15. Oberleithner H, Peters W, Kusche-Vihrog K, Korte S, Schillers H, et al. (2011) Salt overload damages the glycocalyx sodium barrier of vascular endothelium. Pflugers Arch 462: 519-528.
16. Siegel G, Malmsten M, Klussendorf D, Walter A, Schnalke F, et al. (1996) Blood-flow sensing by anionic biopolymers. J Auton Nerv Syst 57: 207-213.
17. Anselm E, Socorro VF, Dal-Ros S, Schott C, Bronner C, et al. (2009) Crataegus special extract WS 1442 causes endothelium-dependent relaxation via a redox-sensitive Src- and Akt-dependent activation of endothelial NO synthase but not via activation of estrogen receptors. J Cardiovasc Pharmacol 53: 253-260.
18. Brixius K, Willms S, Napp A, Tossios P, Ladage D, et al. (2006) Crataegus special extract WS 1442 induces an endothelium-dependent, NO-mediated vasorelaxation via eNOS-phosphorylation at serine 1177. Cardiovasc Drugs Ther 20: 177-184.
19. Al MS, Sweidan H, Mullner S, Jacob R, (1996) Myocardial protection by pretreatment with Crataegus oxyacantha: an assessment by means of the release of lactate dehydrogenase by the ischemic and reperfused Langendorff heart. Arzneimittelforschung 46: 25-27.
20. Veveris M, Koch E, Chatterjee SS, (2004) Crataegus special extract WS 1442 improves cardiac function and reduces infarct size in a rat model of prolonged coronary ischemia and reperfusion. Life Sci 74: 1945-1955.
21. Chatterjee SS, Koch E, Jaggy H, Krzeminski T, (1997) [In vitro and in vivo studies on the cardioprotective action of oligomeric procyanidins in a Crataegus extract of leaves and blooms]. Arzneimittelforschung 47: 821-825.
22. Holubarsch CJ, Colucci WS, Meinertz T, Gaus W, Tendera M, (2008) The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial. Eur J Heart Fail 10: 1255-1263.
23. Koller M, Lorenz W, Aubke W, Jensen A, Gerlach FM, et al. (2006) [Crataegus special extract WS 1442 in the treatment of early stages of CHD-associated heart failure]. MMW Fortschr Med 148: 42.
24. Leuchtgens H, (1993) [Crataegus Special Extract WS 1442 in NYHA II heart failure. A placebo controlled randomized double-blind study]. Fortschr Med 111: 352-354.
25. Tauchert M, Gildor A, Lipinski J, (1999) [High-dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure]. Herz 24: 465-474.
26. Tauchert M, (2002) Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure. Am Heart J 143: 910-915.
27. Weikl A, Assmus KD, Neukum-Schmidt A, Schmitz J, Zapfe G, et al. (1996) [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)]. Fortschr Med 114: 291-296.
28. Zapfe JG, (2001) Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II. Phytomedicine 8: 262-266.
29. Zick SM, Gillespie B, Aaronson KD, (2008) The effect of Crataegus oxycantha Special Extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure. Eur J Heart Fail 10: 587-593.
30. Koch E, Malek FA, (2011) Standardized extracts from hawthorn leaves and flowers in the treatment of cardiovascular disorders-preclinical and clinical studies. Planta Med 77: 1123-1128.
31. Kasas S, Dietler G, (2008) Probing nanomechanical properties from biomolecules to living cells. Pflugers Arch 456: 13-27.
32. Muller DJ, Dufrene YF, (2011) Atomic force microscopy: a nanoscopic window on the cell surface. Trends Cell Biol 21: 461-469.
33. Dvorak HF, (2010) Vascular permeability to plasma, plasma proteins, and cells: an update. Curr Opin Hematol 17: 225-229.
34. Gao L, Lipowsky HH, (2009) Measurement of solute transport in the endothelial glycocalyx using indicator dilution techniques. Ann Biomed Eng 37: 1781-1795.
35. Yuan W, Li G, Gil ES, Lowe TL, Fu BM, (2010) Effect of surface charge of immortalized mouse cerebral endothelial cell monolayer on transport of charged solutes. Ann Biomed Eng 38: 1463-1472.
36. Iyer S, Gaikwad RM, Subba-Rao V, Woodworth CD, Sokolov I, (2009) Atomic force microscopy detects differences in the surface brush of normal and cancerous cells. Nat Nanotechnol 4: 389-393.
37. O'Callaghan R, Job KM, Dull RO, Hlady V, (2011) Stiffness and heterogeneity of the pulmonary endothelial glycocalyx measured by atomic force microscopy. Am J Physiol Lung Cell Mol Physiol 301: L353-L360.
38. Kusche-Vihrog K, Urbanova K, Blanque A, Wilhelmi M, Schillers H, et al. (2011) C-reactive protein makes human endothelium stiff and tight. Hypertension 57: 231-237.
39. Sui X, Chen Q, Hempenius MA, Vancso GJ, (2011) Probing the Collapse Dynamics of Poly(N-isopropylacrylamide) Brushes by AFM: Effects of Co-nonsolvency and Grafting Densities. Small 7: 1440-1447.
40. Pries AR, Secomb TW, (2005) Microvascular blood viscosity in vivo and the endothelial surface layer. Am J Physiol Heart Circ Physiol 289: H2657-H2664.
41. Chappell D, Dorfler N, Jacob M, Rehm M, Welsch U, et al. (2010) Glycocalyx protection reduces leukocyte adhesion after ischemia/reperfusion. Shock 34: 133-139.
42. Petri B, Phillipson M, Kubes P, (2008) The physiology of leukocyte recruitment: an in vivo perspective. J Immunol 180: 6439-6446.
43. Ebong EE, Macaluso FP, Spray DC, Tarbell JM, (2011) Imaging the endothelial glycocalyx in vitro by rapid freezing/freeze substitution transmission electron microscopy. Arterioscler Thromb Vasc Biol 31: 1908-1915.
44. Curry FE, Adamson RH, (2011) Endothelial Glycocalyx: Permeability Barrier and Mechanosensor. Ann Biomed Eng In press.
45. Freedman JE, Parker C III, Li L, Perlman JA, Frei B, et al. (2001) Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103: 2792-2798.
46. Iijima K, Yoshizumi M, Hashimoto M, Akishita M, Kozaki K, et al. (2002) Red wine polyphenols inhibit vascular smooth muscle cell migration through two distinct signaling pathways. Circulation 105: 2404-2410.